Stocks
Perspective Therapeutics, Inc.CATX
AMEXHealthcareBiotechnology$4.17
A clinical-stage radiopharmaceutical company focused on developing targeted alpha-particle therapies for the treatment of cancer. Its pipeline centers on precision radiopharmaceuticals designed to deliver radioactive isotopes directly to tumors while limiting damage to surrounding tissue. Investors ...
52W Range: $1.60 – $6.16
Congressional Interest in Perspective Therapeutics, Inc. (CATX)
No congressional trades have been disclosed for Perspective Therapeutics, Inc. (CATX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading CATX?
No congressional trades found for this stock.